Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 2006 + web + 0.30  Related to the article below (Last Update: 8/4/2008)


FLEXNEWS
ArvinMeritor Reports Third-Quarter Fiscal Year 2008 Results
istockAnalyst.com, OR - Jul 29, 2008
ArvinMeritor's initial Performance Plus initiative, launched in December 2006 , will fully achieve the company's 2008 target of $75 million in savings net ...
George Weston Limited - Quarterly Report to Shareholders Canada NewsWire (press release)
all 952 news articles »  TSE:WN - ARM - TSE:L

CPI Financial
ADP Reports Fiscal 2008 Results; Provides Fiscal 2009 Guidance
Trading Markets (press release), CA - Jul 31, 2008
ADP's news releases, current financial information, SEC filings and Investor Relations presentations are accessible at the same Web site. ...
Investor Relations Earnings Release MarketWatch
Banner Corporation Announces Second Quarter Results; Includes ... MarketWatch
all 1,014 news articles »  XEL - ADP - BANR
American Medical Systems Reports Second Quarter Revenue of $129.8 ...
MarketWatch - Jul 29, 2008
A live web cast of the call will be available through the Company's corporate website at www.AmericanMedicalSystems.com and available for replay three hours ...
Samuel Manu-Tech Inc. - Second quarter results Canada NewsWire (press release)
all 30 news articles »  AMMD - TSE:SMT

RTT News
Omnicare Reports Second Quarter Results
Genetic Engineering News (press release), NY - Jul 31, 2008
The conference call will be webcast live at Omnicare's Web site at www.omnicare.com by clicking on "Investors" and then on "Conference Calls," and will be ...
Mothers Work Reports Third Quarter Fiscal 2008 Earnings Earthtimes (press release)
all 475 news articles »  OCR - MWRK
Prophecy drills 45.5 metres of 0.33% copper and 0.003% Molybdenum ...
Canada NewsWire (press release), Canada - Jul 28, 2008
At Okeover, the objectives of the recent program were achieved and expanded the mineralized area of the North Lake Zone (calculated in 2006 by NC Carter, ...CVE:PCY - TSE:X - CVE:ETF
Canadian Oil Sands Trust raises quarterly distribution to $1.25 ...
FOXBusiness - Jul 29, 2008
Syncrude has participated in this program since inception and had its results externally verified in both 2006 and 2007. Syncrude received two awards for ...TSE:COS.UN
Cadence Reports Q2 Revenue of $329 Million
MarketWatch - Jul 23, 2008
Attendees are asked to register at the Web site at least 10 minutes prior to the scheduled webcast. An archive of the webcast will be available starting ...CDNS
Emera Reports Q2 2008 Earnings of $42.9 million
Canada NewsWire (press release), Canada - Aug 1, 2008
Visit Emera on the web at www.emera.com. Management's Discussion & Analysis As at August 1, 2008 Management's Discussion and Analysis ("MD&A") provides a ...TSE:EMA
Sovereign Bancorp, Inc. Announces Second Quarter 2008 Results
MSN Money - Jul 23, 2008
Investors, analysts and other interested parties will have the opportunity to listen to a live web-cast of Sovereign's Second Quarter 2008 earnings call on ...SOV
Progress Energy Increases 2008 Production Guidance
istockAnalyst.com, OR - Jul 31, 2008
This information is also accessible on the Trust's web site at www.progressenergy.com. We remain firmly focused on our goal of maintaining or modestly ...TSE:PGX.UN
Source: Google News

… This article has been selected for the open discussion forum on the STS Web site: http://www. sts. … -
A Yamaguchi, T Ino, H Adachi, S Murata, H Kamio, M … - The Annals of Thoracic Surgery, 1998 - Soc Thorac Surgeons
... dysfunction (a preoperative EF of less than 0.30) as a ... open discussion forum on the
STS Web site: http ... at Google Indexer on September 27, 2006 ats.ctsnetjournals ...

Detecting spam web pages through content analysis -
A Ntoulas, M Najork, M Manasse, D Fetterly - … of the 15th international conference on World Wide Web, 2006 - portal.acm.org
... WWW 2006, May 23?26, 2006, Edinburgh, Scotland. ... score 1, since 100% of the words
on the web page were ... 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 0.50 0.55 ...

Web Retrieval Experiments with the EuroGOV Corpus at the University of Hildesheim -
N Jensen, R Hackl, T Mandl, R Str?tgen - This Volume, 2006 - Springer
... 0.20 0.25 0.30 ... Document Engineering Track (DE). SAC?06, April, 23-27, 2006, Dijon,
France. 2. Craswell, N., Hawking, D.: Overview of the TREC-2004 Web Track. ...

[PDF] Web searcher interaction with the Dogpile. com metasearch engine -
BJ Jansen, A Spink, S Koshman - Journal of the American Society for Information Science and …, 2007 - ist.psu.edu
... India 4,542 0.30% ... is similar to what was found for users of other Web search en ... (2006)
found that the most frequently used Vivisimo terms used were download, new ...
-

[PDF] Names and similarities on the web: Fact extraction in the fast lane -
M Pasca, D Lin, J Bigham, A Lifchits, A Jain - Procs. of ACL/COLING, 2006 - acl.ldc.upenn.edu
... c 2006 Association for Computational Linguistics ... of candidate facts collected from
noisy Web documents ... Beyonce Knowles 0.32, Bruce Springsteen 0.30, Faith Hill ...
-

[PDF] … of a web-based teaching module and gender on accounting students? ethical judgements Copyright 2006 …
W James, L McManus, N Subramaniam - eprints.qut.edu.au
Page 1. 1 A study on the effect of a web-based teaching module and gender on accounting
students? ethical judgements Copyright 2006 (The authors) ...
-

Innovation generation in charity promotional web sites -
R Bennett - Management, 2006 - emeraldinsight.com
... sense of their attempts at innovation (Dwyer et al., 1987), norms emerge and knowledge
overlap occurs (Roy et al., 2004; Kim et al., 2006). Web site marketing ...

Workload Characterization for the Multimedia Files Embedded in the Popular Web Pages -
A Abhari, M Soraya - actapress.com
... February 2006 popular data set and candidate models. 140 0.00 0.10 0.20 0.30 0.40
0.50 0.60 0.70 0.80 0.90 1.00 1 10 100 1000 10000 100000 1000000 10000000 Web ...

A comparison of implicit and explicit links for web page classification -
D Shen, JT Sun, Q Yang, Z Chen - … of the 15th international conference on World Wide Web, 2006 - portal.acm.org
... World Wide Web Conference Com- mittee (IW3C2). Distribution of these papers is limited
to classroom use, and personal use by others. WWW 2006, May 23?26, 2006 ...

Web Mining for Lexical Context-Specific Paraphrasing -
S Zhao, T Liu, X Yuan, S Li, Y Zhang - ????????????????? - Springer
... from March 15, 2006 to April 5, 2006 are downloaded. ... Web Mining for Lexical
Context-Specific Paraphrasing ... these thresholds are empirically set 0.30, 0.60, and ...

Source: Google Scholar
 
 

Majority Of Anemic Chronic Kidney Disease Pre-Dialysis Patients Achieved Target Hemoglobin Range With PROCRIT(R) (Epoetin Alfa) Therapy

Article Date: 20 Nov 2006 - 0:00am (PST)
Today, at the American Society of Nephrology's 39th Annual Meeting and Scientific Exposition, data was presented for the first time on the initiation of PROCRIT(R) (Epoetin alfa) therapy 20,000 Units once every two weeks in patients with anemia related to chronic kidney disease (CKD) who are not on dialysis. The FDA-approved initiation dose of PROCRIT for this patient population is 50-100 Units/kg three times per week.

In the study, the majority (>88 percent) of patients treated with PROCRIT 20,000 Units once every two weeks achieved a target hemoglobin (Hb) of between 11 and 12 grams per deciliter of blood (g/dL). The mean Hb reached the target range by week six and stayed in that range for the remainder of the 28-week study.

"These results suggest that anemic CKD patients not on dialysis may be administered PROCRIT less frequently at an initiation dose of 20,000 Units once every two weeks," explained the study's principal investigator, Robert Benz, MD, Chief, Division of Nephrology, Lankenau Hospital & Research Center in Wynnewood, PA.

Article continues below and (thank you)
 
Study Design

This prospective, open-label, single-arm, multi-center study investigated the effect of PROCRIT 20,000 Units administered once every two weeks on hemoglobin response. The primary endpoint of the study was the percentage of patients who achieved and maintained a hemoglobin level between 11 and 12 grams per deciliter of blood for at least two consecutive weeks by study week 28. The product labeling for PROCRIT recommends a target hemoglobin range between 10 and 12 grams per deciliter of blood.

The study included 67 patients with chronic kidney disease not on dialysis who had a baseline Hb level of <11g/dL. Patients were treated with a starting dose of PROCRIT 20,000 Units administered once every two weeks for up to 27 weeks, with final hemoglobin assessments performed at week 28. Dose adjustment was allowed after four weeks of treatment. Overall, PROCRIT increased Hb levels by 1 g/dL and 2 g/dL from the start of the trial in 91 percent and 78 percent of patients, respectively.

PROCRIT was well tolerated with most adverse events being mild to moderate and typical of patients with chronic kidney disease.

The study findings suggest the need for well-controlled clinical trials to evaluate the efficacy and safety of extended initiation dosing regimens of PROCRIT for the treatment of CKD-related anemia in patients not on dialysis. Ortho Biotech Products, L.P., markets of PROCRIT (Epoetin alfa). Dr. Benz received research support from Ortho Biotech Clinical Affairs, L.L.C.
 
About Chronic Kidney Disease and Anemia

Chronic kidney disease is a progressive condition in which the kidneys are unable to function effectively. As the kidneys' ability to function decreases, they become unable to help the body produce red blood cells, which contain oxygen-carrying hemoglobin, resulting in anemia. More than 20 million Americans have chronic kidney disease, and as many as two-thirds will develop anemia.

Anemia is a potentially debilitating condition that occurs when the body does not have enough red blood cells, which carry oxygen. Oxygen acts like fuel for the body, providing energy for muscles and organs to work. The kidneys produce erythropoietin, a hormone that tells the body to make red blood cells. As kidney function declines, the body may not make enough red blood cells, resulting in anemia. Symptoms of anemia include feeling tired or weak, shortness of breath, dizziness, decreased ability to concentrate and paleness.

About PROCRIT(R) (Epoetin alfa)

PROCRIT(R) (Epoetin alfa) is a prescription medication for the treatment of anemia in chronic kidney disease patients who are not on dialysis and is injected by doctors or nurses.

PROCRIT(R) is not for patients with uncontrolled high blood pressure. High blood pressure has been noted in patients treated with PROCRIT(R) and blood pressure should be monitored carefully. Drugs like PROCRIT(R) may increase the risk of blood clots and seizures.

Loss of response to PROCRIT(R) could be a sign of a very rare but serious condition. In studies, the most common side effects were high blood pressure, headache, joint pain and nausea.

Please visit http://www.PROCRIT.com for full prescribing information.

About Ortho Biotech Products, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients' health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit http://www.orthobiotech.com.

Ortho Biotech Products, L.P.
http://www.orthobiotech.com
 
Google
Web www.iconocast.com